Ann: Appendix 4C and Quarterly Update, page-62

Hi Thrifty Clown,

Your last post was a very good précis on where we are now and head winds that we may foresee.

In relation to “ vet major “ not consummating the deal, can you respond to how you feel, that we had 8 cohort dogs in the trial. Most people scientific or otherwise would think that it would be a difficult ask on a big pharmaceutical Company to accept the limited data in a manner whereby it would be profitable to commercialise the product.

Where did we go wrong and as a Company did we think that eight again is enough, I appreciate that this number will increase, but initially it was a small number again as stated by PAA.

Can, you give us an insight on where they went wrong and why considering the impeccable credentials they have?

Cheers kpax